JP5538675B2 - Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition - Google Patents
Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition Download PDFInfo
- Publication number
- JP5538675B2 JP5538675B2 JP2007298966A JP2007298966A JP5538675B2 JP 5538675 B2 JP5538675 B2 JP 5538675B2 JP 2007298966 A JP2007298966 A JP 2007298966A JP 2007298966 A JP2007298966 A JP 2007298966A JP 5538675 B2 JP5538675 B2 JP 5538675B2
- Authority
- JP
- Japan
- Prior art keywords
- pelago
- extract
- algae
- containing composition
- algae extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、微細藻類の一種であるペラゴ藻のサルシノクリシスの藻体から得られる抽出物であり、例えば、ヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性等の作用を有するペラゴ藻抽出物含有組成物と、該ペラゴ藻抽出物含有組成物を配合する食品及び化粧料に関するものである。 The present invention is an extract obtained from the algal body of the sarcinolysis of Pelago algae which is a kind of microalgae, and contains, for example, a Pelago algae extract having actions such as hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability and antibacterial activity The present invention relates to a composition and a food and a cosmetic containing the Pelago algae extract-containing composition.
近年のアレルギー患者数は急激に増え続けており、体質だけでなく、生活環境や食生活の乱れによる影響も考えられる。人体に安全で副作用を持たない抗アレルギー食品素材として甜茶エキスやシソ葉エキスがすでに広く認知されており、臨床研究、動物実験でアレルギー症状を緩和、予防することが確認されている。(耳鼻咽喉科展望;Vol.38,No.4,519〜532 1995、炎症;Vol.15,No.2,167〜173 1995)(Fragrance jounal;Vol.23,No.5,43〜48 1995、Vol.23,No.7,90〜94 1995) In recent years, the number of allergic patients has been increasing rapidly, and not only the constitution but also the influence of living environment and disorder of eating habits can be considered. As tea ingredients and perilla leaf extracts are already widely recognized as anti-allergic food materials that are safe for the human body and have no side effects, clinical studies and animal experiments have been confirmed to alleviate and prevent allergic symptoms. (Otolaryngology perspective; Vol. 38, No. 4, 519 to 532 1995, inflammation; Vol. 15, No. 2, 167 to 173 1995) (Fragrance journal; Vol. 23, No. 5, 43 to 48 1995) Vol. 23, No. 7, 90-94 1995).
植物由来のヒアルロニダーゼ阻害剤は、日常的に摂取することで、風邪に伴う炎症やのどのはれ、花粉症、せきなどを予防・改善することができ、同時に、これらのヒアルロニダーゼ阻害剤を含む化粧品の使用により、皮膚のかゆみなどを改善することが可能であり、更に強力なヒアルロン酸分解阻害剤として皮膚や動脈壁、関節腔などに含まれるヒアルロン酸含量の低下を抑制し、間接的作用ではあるが、皮膚の保湿性および柔軟性を高め、加齢に伴う動脈効果を予防し、関節炎の改善などに寄与する発明が公知になっている。(特許文献1参照) Plant-derived hyaluronidase inhibitors can be taken daily to prevent or improve inflammation, throat swelling, hay fever, cough, etc. associated with colds. At the same time, cosmetics containing these hyaluronidase inhibitors It is possible to improve the itching of the skin, and as a more potent hyaluronic acid degradation inhibitor, it suppresses the decrease in the hyaluronic acid content contained in the skin, arterial wall, joint space, etc. There are known inventions that increase the moisture retention and flexibility of the skin, prevent arterial effects associated with aging, and contribute to the improvement of arthritis. (See Patent Document 1)
一方、ストレスや紫外線、大気汚染等は活性酸素の原因となり、体内で酸化が進むと生活習慣病や老化として現れてくる。現代の社会環境において、ストレスは万病の元といっても過言ではなく、その対処法が難しい。また、オゾン層破壊による紫外線量の増加や自動車からの排気ガス等様々な活性酸素から身を守ることは健康を保つために重要となる。近年ではストレスを軽減する目的で、水溶性抗酸化物質でもあるビタミンCやビタミンB群のサプリメントを利用することも勧められおり、しみの予防改善にも水溶性抗酸化物質のビタミンCが利用されている。 On the other hand, stress, ultraviolet rays, air pollution, and the like cause active oxygen, and when oxidation progresses in the body, it appears as a lifestyle-related disease or aging. In the modern social environment, stress is not an exaggeration to say that it is the cause of all illness, and it is difficult to deal with it. In addition, protecting the body from various active oxygens such as an increase in the amount of ultraviolet rays due to ozone layer destruction and exhaust gas from automobiles is important for maintaining health. In recent years, for the purpose of reducing stress, it is also recommended to use vitamin C and vitamin B group supplements, which are water-soluble antioxidants, and vitamin C, a water-soluble antioxidant, is also used to prevent and improve stains. ing.
また、化粧品素材として広く認知されているヒアルロン酸は、動物由来や微生物を利用した醗酵のもので保湿効果が高いため、化粧料の保湿剤として多くの商品に利用されている。また、ヒアルロン酸は肌の保湿効果だけでなく、関節液や軟骨の成分で、炎症を抑える食品としても利用されている。 Hyaluronic acid, which is widely recognized as a cosmetic material, is fermented using animal origin and microorganisms and has a high moisturizing effect, so it is used in many products as a moisturizing agent for cosmetics. Hyaluronic acid is not only a skin moisturizing effect but also a synovial fluid and cartilage component and is used as a food to suppress inflammation.
更に、現在化粧料に使用されている抗菌剤は、ほとんどが合成原料であり、中でもパラベンは接触性皮膚炎、アレルギー性皮膚炎の原因物質となる可能性が高いとされている。更に、その化学構造が環境ホルモンのノニルフェノールに似ており、人の正常なホルモン作用に異常を起こしたり、人体に蓄積して妊娠中の胎児に悪影響を与えるといわれている。 Furthermore, most antibacterial agents currently used in cosmetics are synthetic raw materials, and parabens are considered to have a high possibility of causing causative dermatitis and allergic dermatitis. Furthermore, its chemical structure is similar to the environmental hormone nonylphenol, and it is said to cause abnormalities in the normal hormonal action of humans and to accumulate in the human body and adversely affect the fetus during pregnancy.
ところで、近年、自然素材である微細藻類を原料とする化粧類や食品が注目されている。この微細藻類を使用するための技術としては、例えば、単細胞藻を構成する多糖体であって、ペラゴ藻綱に属する単細胞藻から剥がした外被を構成する多糖体であることを特徴とする単細胞藻の外被から得られた多糖体がある(特許文献2参照)。 By the way, in recent years, cosmetics and foods made from natural algae, which are natural materials, have attracted attention. As a technique for using this microalgae, for example, a polysaccharide constituting a unicellular algae, which is a polysaccharide constituting an envelope peeled from a unicellular algae belonging to the Pelagophyceae There is a polysaccharide obtained from the outer coat of algae (see Patent Document 2).
この特許文献2の公知技術においては、ペラゴ藻の藻体自体を利用するものではなく、ペラゴ藻の単細胞藻から剥がした外被を構成する多糖体を利用する技術に関するものである。
The known technique of
従来、黄色植物門ペラゴ藻網サルシノクリシス目であるサルシノクリシスは、藻体の周りに多糖を持ち、熱により外れやすい性質を持っている。これまでその多糖を用いて生分解性プラスチックや浄水剤の開発が行われているが、構造解析や生理活性に関する報告はない。 Conventionally, sarcinolysis, which is a yellow plant gate Pelagophyceae sarcinolysis, has a polysaccharide around the alga body and has the property of being easily detached by heat. So far, biodegradable plastics and water purification agents have been developed using the polysaccharide, but there are no reports on structural analysis or physiological activity.
従って、本発明の目的としては、従来報告されていない種類の微細藻類からの抽出物を有効成分とするヒアルロニダーゼ阻害活性、抗酸化活性及び保湿能を併せ持つ素材乃至抗菌剤を提供し、また更に、該剤を含有する食品および化粧料を提供するということを課題とするものである。 Therefore, as an object of the present invention, there is provided a material or antibacterial agent having both hyaluronidase inhibitory activity, antioxidant activity and moisturizing ability, which contains an extract from a kind of microalgae not reported in the past as an active ingredient. It is an object of the present invention to provide foods and cosmetics containing the agent.
本発明者等は、上記の課題を解決し、所期の目的を達成するために微細藻類について鋭意検討を行った結果、黄色植物門ペラゴ藻網サルシノクリシス目であるサルシノクリシスに属する微細藻類の抽出物がヒアルロニダーゼ阻害活性、抗酸化活性、保湿能乃至抗菌活性を有していることを見出して本発明を完成するに至った。 As a result of intensive studies on microalgae in order to solve the above-mentioned problems and achieve the intended purpose, the present inventors have found that the extract of microalgae belonging to sarcinolysis, which is the yellow plant Pelagophyceae sarcinolysis Was found to have hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability or antibacterial activity, and the present invention was completed.
そこで、本発明においては、上記した従来例の課題を解決する具体的手段として本発明に係る第1の発明として、黄色植物門ペラゴ藻綱サルシノクリシス目であるサルシノクリシスの藻体を脱塩処理後に凍結乾燥を行い、該乾燥藻体に水を加えて90℃以上で3時間攪拌抽出を行った後、遠心分離による上清を濾過した熱水抽出液を1/5〜1/6まで濃縮し、これにエタノールを添加して一晩放置後の沈殿物として得られるか、または、前記乾燥藻体に50%エタノールを加えて90℃以上で3時間還流抽出を行った後、遠心分離による上清を濾過し、エタノールを完全除去して得られたヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性を合わせ持つ抽出物を含有していることを特徴とするペラゴ藻抽出物含有組成物を提供するものである。 Therefore, in the present invention, as a first means according to the present invention as a specific means for solving the problems of the above-described conventional example, the algal body of the sarcinolysis that is a yellow plant gate Pelagophyceae Salsinolysis is frozen after desalting. After drying, water was added to the dried alga body and the mixture was stirred and extracted at 90 ° C. or higher for 3 hours , and then the hot water extract obtained by filtering the supernatant by centrifugation was concentrated to 1/5 to 1/6, It can be obtained as a precipitate after adding ethanol to it overnight, or after adding 50% ethanol to the dried alga and performing reflux extraction at 90 ° C. or more for 3 hours , and then supernatant by centrifugation Pelago alga extract-containing composition characterized by containing an extract having hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability and antibacterial activity obtained by filtering and completely removing ethanol You It is intended.
また、第2の発明として、前記第1の発明のヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性を合わせ持つペラゴ藻抽出物含有組成物を0.1%含有していることを特徴とする食品、及び第3の発明として、前記第1の発明のペラゴ藻抽出物含有組成物を0.1〜0.3%含有していることを特徴とする化粧料を提供するものである。 Further, as a second invention, the composition contains 0.1% of a Pelago algae extract-containing composition having the hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability and antibacterial activity of the first invention. As a third invention, there is provided a cosmetic comprising 0.1 to 0.3% of the Pelago algae extract-containing composition of the first invention.
本発明の第1の発明に係るペラゴ藻抽出物含有組成物は、黄色植物門ペラゴ藻綱サルシノクリシス目であるサルシノクリシスの藻体から抽出されたヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性を合わせ持つ抽出物を含有しているものであるため、これらの特性を生かした素材として利用できるものであり、これらの特性を生かした製品、例えば、ヒアルロニダーゼ阻害活性剤または抗菌剤等として利用することができるばかりでなく、前記ペラゴ藻抽出物含有組成物を食品または化粧料等に配合させることによって、ヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性等の特性を生かした食品及び化粧料を提供できるという優れた効果を奏する。
The Pelago algae extract-containing composition according to the first aspect of the present invention has hyaluronidase inhibitory activity, antioxidative activity, moisturizing ability and antibacterial activity extracted from the algal body of Salsinoclisis, which is a yellow plant Pelagophyceae Salsinolytica. Since it contains an extract with a combination, it can be used as a material that takes advantage of these characteristics, and it can be used as a product that takes advantage of these characteristics , such as a hyaluronidase inhibitor or an antibacterial agent. In addition , foods and cosmetics that make use of characteristics such as hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability, and antibacterial activity can be obtained by incorporating the above-mentioned composition of Pelago algae extract into foods or cosmetics. There is an excellent effect that it can be provided.
次に、本発明を具体的な実施の形態に基づいて詳しく説明する。
本発明の実施の形態に係るペラゴ藻抽出物含有組成物は、黄色植物門ペラゴ藻網(Pelagophyceae)サルシノクリシス目(Sarcinochrysidales)であるサルシノクリシス(Sarcinochrysis)の藻体から抽出された抽出物を含有するものであり、また、前記ペラゴ藻抽出物含有組成物を配合した食品及び化粧料である。
Next, the present invention will be described in detail based on specific embodiments.
Perago alga extract containing composition according to the embodiment of the present invention are those containing an extract extracted from algae of a yellow plant Gate Perago Momo (Pelagophyceae) Sarushinokurishisu th (Sarcinochrysidales) Sarushinokurishisu (Sarcinochrysis) Moreover, it is the foodstuffs and cosmetics which mix | blended the said Pelago algae extract containing composition.
原料として用いる微細藻類の一種であるペラゴ藻のサルシノクリシスとしては、天然のものをその侭利用することもできるが、安定供給の面から培養により増殖させて使用することが望ましい。藻類は光合成を行って自らのエネルギーとしているため、培養は光照射の下に藻類培養用の培地を用い、通常の培養方法により行うことができる。但し、藻類によって培養方法が若干異なるために最適な培養条件を設定する必要があり、具体的な培養条件を述べれば下記の通りである。 As the sarcinolysis of Pelago algae, which is a kind of microalgae used as a raw material, natural ones can be used, but it is desirable to grow them by culturing from the viewpoint of stable supply. Since algae perform photosynthesis and generate their own energy, the culture can be performed by a normal culture method using a culture medium for algae under light irradiation. However, since the culture method differs slightly depending on the algae, it is necessary to set optimal culture conditions. The specific culture conditions are as follows.
〔サルシノクリシスの培養〕
一般的な海産性藻類を培養する際に用いられているものであれば格別な制限はなく、例えば、f/2 mediumを用いることができる。即ち、新鮮な濾過海水999mLに対してNaNO3 75mg、Na2SiO3・9H2O 10mg、Thiamine HCl 0.5μg、Biotin 0.5μg、Cyanocobalamin 100μgを添加した溶液を調製し、これにEDTA 2Na・2H2O 4.4g/L、FeCl3・6H2O 3.16g/L、CoSO4・7H2O 12mg/L、ZnSO4・7H2O 21mg/L、MnSO4・4H2O 180mg/L、CuSO4・5H2O 7mg/L、Na2MoO4・2H2O 7mg/Lを含有する微量元素混合液を1mL添加した後、121℃、20分間オートクレーブ滅菌をし、NaH2PO4・H2O 6mgを添加することにより培地を調製した。この培地に、サルシノクリシス(Sarcinochrysis sp.)の細胞を接種し、2リットル容のガラス製扁平フラスコにて培養した。この時の照度を10−30μ Einsteins/m2/secに設定し、連続光照射下で行うのが好ましい。培養温度は20−30℃であり、25℃付近が望ましい。
[Culture of sarcinolysis]
If it is used when cultivating general marine algae, there will be no special restriction | limiting, For example, f / 2 medium can be used. That is, a solution prepared by adding 75 mg of NaNO 3 , 10 mg of Na 2 SiO 3 .9H 2 O, 0.5 μg of Thiamine HCl, 0.5 μg of Biotin, and 100 μg of Cyanocobalamin to 999 mL of fresh filtered seawater was prepared, and EDTA 2Na · 2H 2 O 4.4 g / L, FeCl 3 · 6H 2 O 3.16 g / L, CoSO 4 · 7H 2 O 12 mg / L, ZnSO 4 · 7H 2 O 21 mg / L, MnSO 4 · 4H 2 O 180 mg / L , CuSO 4 · 5H 2 O 7 mg / L, Na 2 MoO 4 · 2H 2 O 7 mg / L containing 1 mL of a trace element mixture was added, then autoclaved at 121 ° C. for 20 minutes, and NaH 2 PO 4 · The medium was prepared by adding 6 mg of H 2 O. The medium was inoculated with Sarcinochrysis sp. Cells and cultured in a 2-liter glass flat flask. The illuminance at this time is preferably set to 10-30 μEinsteins / m 2 / sec, and it is preferably performed under continuous light irradiation. The culture temperature is 20-30 ° C, preferably around 25 ° C.
このようにして得られたサルシノクリシスの藻体から抽出物を抽出してペラゴ藻抽出物含有組成物を製造する方法と、該ペラゴ藻抽出物含有組成物のヒアルロニダーゼ阻害活性試験、抗酸化試験、保湿試験、安全性試験、抗菌試験と、抗炎症剤、抗酸化剤、保湿剤或いは抗菌剤の製造方法とに関するより具体的な実施例を挙げ、本発明を更に詳しく説明する。 A method for producing an extract-containing composition containing Pelago algae by extracting an extract from the algal bodies of the sarcinolysis obtained in this way, a hyaluronidase inhibitory activity test, an antioxidant test, and a moisturizing composition of the Pelago algae extract-containing composition The present invention will be described in more detail by giving more specific examples regarding tests, safety tests, antibacterial tests, and methods for producing anti-inflammatory agents, antioxidants, humectants or antibacterial agents.
[実施例1]
この実施例1においては、以下のようにして製造した。
(熱水による抽出物の抽出方法)
収穫したサルシノクリシスの藻体を脱塩処理後、凍結乾燥を行い、得られた乾燥藻体5gに水1000mLを加え、90℃以上で3時間攪拌抽出を行った。その後、遠心分離を行い、上清をガラスフィルターにてろ過をして熱水抽出液を得た。この熱水抽出液を1/5〜1/6まで濃縮し、4倍容量のエタノールを添加して一晩放置後、沈殿物を回収し、凍結乾燥して粉末を得て、これを実施例1とした。
[Example 1]
In this Example 1, it manufactured as follows.
(Extraction method of extract with hot water)
The harvested salsinolysis algal bodies were desalted and then freeze-dried. To 5 g of the obtained dried algal bodies, 1000 mL of water was added, and the mixture was extracted by stirring at 90 ° C. or more for 3 hours. Thereafter, centrifugation was performed, and the supernatant was filtered through a glass filter to obtain a hot water extract. This hot water extract was concentrated to 1/5 to 1/6, 4 volumes of ethanol was added and allowed to stand overnight, and then the precipitate was recovered and freeze-dried to obtain a powder. It was set to 1.
[酸性糖の確認]
藻類には生理活性を持つ酸性糖がいくつか知られていることから、前記実施例1に含まれる酸性糖を調べるため、イオン交換樹脂による精製を行った。イオン交換樹脂はDEAE−TOYOPAL(デアエ−トヨパール)650Mを使用し、溶出溶媒は、水と1M塩化ナトリウム溶液でグラジエント溶出を行った。その結果を表1に示す。
[Confirmation of acid sugar]
Since some algae having a physiological activity are known for algae, in order to investigate the acidic sugar contained in Example 1, purification with an ion exchange resin was performed. DEAE-TOYOPAR (650M) was used as the ion exchange resin, and the elution solvent was gradient elution with water and 1M sodium chloride solution. The results are shown in Table 1.
(表1)
(Table 1)
[構成糖の確認]
次に、前記実施例1を構成する構成糖を調べるため、ガスクロマトグラフィーによる分析を行った。すなわち、加水分解した前記実施例1に水素化ホウ素ナトリウム10mg、1Mアンモニア水0.1mLを加え、40℃で90分間保持後、無水酢酸0.1mLで還元反応を停止した。次に、1−メチルイミダゾール 0.2mL、無水酢酸2mLの順で加え、室温で40分間超音波をかけることでアセチル化を行った。更に約2mLの蒸留水で反応停止後、冷却しつつクロロホルム2mLを加え、抽出し、クロロホルム層は蒸留水で洗浄後、無水硫酸ナトリウムで脱水し、濃縮後に少量のアセトンを加えた。その結果を表2に示す。
[Confirmation of component sugar]
Next, in order to investigate the constituent sugars constituting Example 1, analysis by gas chromatography was performed. That is, 10 mg of sodium borohydride and 0.1 mL of 1M aqueous ammonia were added to the hydrolyzed Example 1, and maintained at 40 ° C. for 90 minutes, and then the reduction reaction was stopped with 0.1 mL of acetic anhydride. Next, 0.2 mL of 1-methylimidazole and 2 mL of acetic anhydride were added in this order, and acetylation was performed by applying ultrasonic waves at room temperature for 40 minutes. Further, after stopping the reaction with about 2 mL of distilled water, 2 mL of chloroform was added while cooling and extraction was performed. The chloroform layer was washed with distilled water, dehydrated with anhydrous sodium sulfate, and concentrated, and then a small amount of acetone was added. The results are shown in Table 2.
(表2)
(Table 2)
これら表1及び表2の結果より、サルシノクリシスの多糖は、中性糖が95.8%、酸性糖が3.69%で、その構成比は、アラビノース:キシロース:マンノース:グルコース=1.7:1.2:0.4:0.04であることが分かった。 From the results of Tables 1 and 2, the polysaccharide of sarcinolysis is 95.8% neutral sugar and 3.69% acidic sugar, and the composition ratio is arabinose: xylose: mannose: glucose = 1.7: It was found to be 1.2: 0.4: 0.04.
[試験例1]
この試験例1においては、前記実施例1について、下記の方法でそのヒアルロニダーゼ阻害活性を測定した。その結果を表3に示す。
(ヒアルロニダーゼ阻害活性試験方法)
0.1M酢酸緩衝液(pH4.0)に溶解した被験試料と同緩衝液を合わせて0.2mL試験管に取り、同緩衝液に溶解したヒアルロニダーゼ溶液(type IV−S 最終酵素活性:400NF units/mL、Sigma社製)を0.1mL加え、37℃で20分間インキュベートし、更に、活性化剤溶液(Compound 48/80 (Sigma社製)、CaCl2、NaClの最終濃度がそれぞれ0.1mg/mL、2.5mM、0.15Mとなるように同緩衝液に溶解したもの)を0.2mL加え、37℃で20分間インキュベートした。
[Test Example 1]
In Test Example 1, the hyaluronidase inhibitory activity of Example 1 was measured by the following method. The results are shown in Table 3.
(Test method for hyaluronidase inhibitory activity)
A test sample dissolved in 0.1 M acetate buffer (pH 4.0) and the same buffer are combined, taken into a 0.2 mL test tube, and a hyaluronidase solution (type IV-S final enzyme activity: 400 NF units) dissolved in the same buffer. / ML, 0.1 mL of Sigma), and incubated at 37 ° C. for 20 minutes. Further, final concentrations of activator solution (Compound 48/80 (Sigma), CaCl 2 , and NaCl are 0.1 mg each. / ML, 2.5 mM, 0.15 M dissolved in the same buffer) was added and incubated at 37 ° C. for 20 minutes.
これに、同緩衝液に溶解したヒアルロン酸Na溶液(最終濃度:0.4mg/mL)を0.5mL加え、37℃で40分間インキュベートした後、0.4N水酸化ナトリウム溶液を0.2mL加えた。氷冷後、ホウ酸溶液(pH9.1)0.2mLを加え、3分間煮沸後氷冷し、p−ジメチルベンズアルデヒド試薬6mLを加え、37℃で20分間インキュベート後、585nmにおける吸光後を測定した。指標として、DSCG(クロモグリク酸ナトリウム)(比較例1)を用いた。また、対照として被験試料の代わりに同緩衝液を用い、それぞれのブランクとして、酵素溶液の代わりに同緩衝液を用いた。なお、阻害活性は次の式から求められる阻害率で表した。
阻害率(%)=〔(A−B)−(C−D)〕/(A−B)×100
A:対照溶液のA585
B:対照溶液のブランクのA585
C:試料溶液のA585
D:試料溶液のブランクのA585
To this, 0.5 mL of a sodium hyaluronate solution (final concentration: 0.4 mg / mL) dissolved in the same buffer was added, incubated at 37 ° C. for 40 minutes, and then 0.2 mL of 0.4N sodium hydroxide solution was added. It was. After cooling with ice, 0.2 mL of boric acid solution (pH 9.1) was added, boiled for 3 minutes, cooled on ice, added with 6 mL of p-dimethylbenzaldehyde reagent, incubated at 37 ° C. for 20 minutes, and then measured after absorption at 585 nm. . As an index, DSCG (sodium cromoglycate) (Comparative Example 1) was used. In addition, the same buffer was used instead of the test sample as a control, and the same buffer was used instead of the enzyme solution as each blank. The inhibitory activity was expressed as an inhibition rate obtained from the following formula.
Inhibition rate (%) = [(A−B) − (C−D)] / (A−B) × 100
A: A 585 of the control solution
B: Control solution blank A 585
C: A 585 of the sample solution
D: Sample solution blank A 585
(表3)
(Table 3)
この表3の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)におけるヒアルロニダーゼ阻害活性は、指標として使用したヒスタミン遊離阻害薬であるDSCG(クロモグリク酸ナトリウム)(比較例1)の2.4倍の阻害活性が認められた。 From the results of Table 3, the hyaluronidase inhibitory activity in the composition containing the extract of Pelago algae according to the present invention (Example 1) is DSCG (sodium cromoglycate) which is a histamine release inhibitor used as an index (Comparative Example 1). Of 2.4 times as much as the inhibitory activity.
この試験法は、花粉症などのI型アレルギー抑制の第1次スクリーニングとして広く用いられているものである。因みに、特開平9−118627号公報によれば、この試験法でDSCGと同等の活性がある甜茶熱水抽出物は日常的に摂取することで炎症や花粉症、せきなどを予防、改善することができ、あるいは化粧品を使用することで皮膚のかゆみなどを改善することができるという報告もされている。 This test method is widely used as a primary screening for suppression of type I allergy such as hay fever. By the way, according to Japanese Patent Laid-Open No. 9-118627, this test method can prevent and improve inflammation, hay fever, cough, etc. by daily ingestion of a hot tea hot water extract that has the same activity as DSCG. It has also been reported that itching can be improved or skin itchiness can be improved by using cosmetics.
また、近年、花粉症は国民病ともいわれ、国民の約2割が花粉症と診断され、更にその予備軍が2割ほど存在すると考えられている。更に、アレルギー性鼻炎、気管支喘、皮膚炎などの治療薬として使用されている抗ヒスタミン剤の服用で不整脈の副作用が発生していることから、安全で副作用のない抗アレルギー剤の開発が進められており、甜茶もその1つであることより、本発明に係るペラゴ藻抽出物含有組成物にも十分その可能性があると考えられる。 In recent years, hay fever is also said to be a national disease, and about 20% of the people are diagnosed with hay fever, and it is thought that there are about 20% of reserves. In addition, the side effects of arrhythmia have occurred due to the use of antihistamines that are used as therapeutic agents for allergic rhinitis, bronchial asthma, dermatitis, etc., and development of antiallergic agents that are safe and free of side effects is being promoted. Since the tea is one of them, it is considered that the composition containing the Pelago algae extract according to the present invention has sufficient potential.
[試験例2]
この試験例2においては、前記実施例1について、下記の方法でその抗酸化活性を測定した。その結果を表4に示す。
(β−カロテン退色法による抗酸化試験方法)
β−カロテン溶液(100mg/100mL,クロロホルム)7.5mL、リノール酸溶液(10g/100mL,クロロホルム)1.0mL、Tween 40溶液(20g/100mL,クロロホルム)5.0mLをナス型フラスコにとり、エバポレーターでクロロホルムを完全にとばした後、水500mLを加え溶解し、リノール酸−β−カロテン溶液を作製した。
[Test Example 2]
In Test Example 2, the antioxidant activity of Example 1 was measured by the following method. The results are shown in Table 4.
(Antioxidation test method by β-carotene fading method)
Take 7.5 mL of β-carotene solution (100 mg / 100 mL, chloroform), 1.0 mL of linoleic acid solution (10 g / 100 mL, chloroform), and 5.0 mL of Tween 40 solution (20 g / 100 mL, chloroform) in an eggplant-shaped flask. After completely skipping chloroform, 500 mL of water was added and dissolved to prepare a linoleic acid-β-carotene solution.
この溶液45mLに、0.2Mリン酸緩衝液(pH6.8)を4mL加え静かに攪拌した。これに被験試料を1mL加え、55℃で加温し、20分ごとに470nmの吸光度を測定した。指標としてBHA(ブチルヒドロキシアニソール)(比較例2)を用いた。また、それぞれのブランクとして、β−カロテン溶液を加えないものについて同様に行った。抗酸化活性は、被験試料添加直後の吸光度値を100とした。 To 45 mL of this solution, 4 mL of 0.2 M phosphate buffer (pH 6.8) was added and gently stirred. 1 mL of the test sample was added thereto, and the mixture was heated at 55 ° C., and the absorbance at 470 nm was measured every 20 minutes. BHA (butylhydroxyanisole) (Comparative Example 2) was used as an index. Moreover, it carried out similarly about what did not add (beta) -carotene solution as each blank. For the antioxidant activity, the absorbance value immediately after addition of the test sample was taken as 100.
(表4)
(Table 4)
この表4の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)における抗酸化活性は、指標として使用した酸化防止剤であるBHA(ブチルヒドロキシアニソール)(比較例2)の1000倍の濃度で同等の抗酸化活性が認められた。 From the results of Table 4, the antioxidant activity in the composition containing Pelago algae extract (Example 1) according to the present invention is that of BHA (butylhydroxyanisole) (Comparative Example 2), which is an antioxidant used as an index. Similar antioxidant activity was observed at 1000 times the concentration.
[試験例3]
この試験例3においては、前記実施例1について、下記の方法でその保湿能を測定した。その結果を図1及び図2に示す。
(保湿試験方法)
あらかじめ測定部位である前腕内側部を石鹸で洗浄し、温度22℃、湿度44%に保った測定室内で20分以上安静にした後、前腕内側部に0.2%被験試料を10μL/cm2塗布し、肌水分測定器(SKIN DIAGNOSTIC SD 27)を使用して肌水分量を測定した。指標としてヒアルロン酸ナトリウム(比較例3)を用いた。対照には被験試料の代わりに水を用い、ブランクとして、何も塗布しない箇所を測定した。水分増加量は、塗布前の肌水分量を1とした。
[Test Example 3]
In Test Example 3, the moisture retention ability of Example 1 was measured by the following method. The results are shown in FIGS.
(Moisturizing test method)
Wash the inner forearm portion in advance measurement site with soap, temperature 22 ° C., after resting for 20 minutes or more at a measuring chamber kept at a humidity of 44%, 0.2% to inner forearm part test sample 10 [mu] L / cm 2 The skin moisture content was measured using a skin moisture meter (SKIN DIAGNOSTIC SD 27). Sodium hyaluronate (Comparative Example 3) was used as an index. As a control, water was used in place of the test sample, and a blank area was measured as a blank. The amount of moisture increase was defined as 1 for the amount of skin moisture before application.
これら図1及び図2の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)における保湿効果は、塗布1分後に塗布前の7倍の水分量となり、その後120分後まで塗布前の3〜5倍以上の水分量を保った。指標として使用した保湿効果の高いヒアルロン酸ナトリウムは、塗布1分後に塗布前の4倍の水分量で、その後120分後まで塗布前の3倍前後の水分量であった。さらにこの実施例1とヒアルロン酸ナトリウムを7日間塗布しつづけた結果、実施例1はヒアルロン酸ナトリウムより高い水分量が保たれた。このことから、ペラゴ藻抽出物含有組成物(実施例1)には保湿効果の高いヒアルロン酸ナトリウムより優れた保湿効果が認められた。 From these results of FIG. 1 and FIG. 2, the moisturizing effect in the composition containing Pelago algae extract (Example 1) according to the present invention is 7 times the amount of water before coating after 1 minute of coating, and until 120 minutes thereafter. The water content of 3 to 5 times or more before coating was maintained. Sodium hyaluronate having a high moisturizing effect used as an index was 4 times the amount of water before coating 1 minute after coating, and about 3 times the amount of water before coating until 120 minutes thereafter. Furthermore, as a result of continuing to apply Example 1 and sodium hyaluronate for 7 days, Example 1 maintained a higher water content than sodium hyaluronate. From this, the moisturizing effect superior to the sodium hyaluronate with a high moisturizing effect was recognized by the composition containing the extract of Pelago algae (Example 1).
[試験例4]
この試験例4においては、前記実施例1について、下記の方法でその安全性試験を行った。その結果を表5に示す。
(パッチテストによる安全性試験方法)
0.3%被験試料(実施例1)および水(比較例4)をパッチテスト用絆創膏(リバテープ製薬(株)製)に0.3mL塗末し、上腕内部に貼付して、24時間後の皮膚の反応を検査した。
[Test Example 4]
In Test Example 4, the safety test of Example 1 was performed by the following method. The results are shown in Table 5.
(Safety test method by patch test)
Apply 0.3 mL of a 0.3% test sample (Example 1) and water (Comparative Example 4) to a patch test adhesive bandage (manufactured by Riba Tape Pharmaceutical Co., Ltd.) and apply it to the inside of the upper arm. The skin reaction was examined.
(表5)
(Table 5)
この表5の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)におけるパッチテスト(安全性試験)の結果は、被験者6名全症例において、陽性反応はなく、このペラゴ藻抽出物含有組成物における安全性が確認された。 From the results of Table 5, the results of the patch test (safety test) in the composition containing the extract of Pelago algae according to the present invention (Example 1) showed no positive reaction in all cases of 6 subjects. The safety of the extract-containing composition was confirmed.
[試験例5]
この試験例5においては、前記実施例1について、下記の方法でそのpH安定性について検査した。その結果を表6に示す。
(pH安定性試験方法)
0.3%被験試料に0.1mol/L HCl又は0.2mol/L NaOHを加え、各pHに調整し、直後のpHと外観、および各温度に一週間放置し、外観を観察した。
[Test Example 5]
In Test Example 5, the pH stability of Example 1 was examined by the following method. The results are shown in Table 6.
(PH stability test method)
0.1 mol / L HCl or 0.2 mol / L NaOH was added to a 0.3% test sample, adjusted to each pH, allowed to stand at the pH and appearance immediately after that, and at each temperature for one week, and the appearance was observed.
(表6)
○:変化なし、△:濁り発生、×:沈殿発生
(Table 6)
○: No change, △: Turbidity, ×: Precipitation
この表6の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)をpH3〜11に調整した溶液の安定性は、1週間各温度で放置後の外観に変化は見られず、化粧品原料として性状的安定性が確認された。
From the results of Table 6, the stability of the solution prepared by adjusting the composition containing Pelago algae extract (Example 1) according to the present invention to
[試験例6]
この試験例6においては、前記実施例1について、下記の方法でその化粧品原料との相溶性について検査した。結果を表7に示す。
(化粧品原料との相溶性試験方法)
0.3%被験試料と表7に記載した化粧品原料を1:1の割合で混合し、直後のpHと外観、および各温度に一週間放置し、外観を観察した。
[Test Example 6]
In Test Example 6, the compatibility with the cosmetic raw material was examined for Example 1 by the following method. The results are shown in Table 7.
(Test method for compatibility with cosmetic ingredients)
A 0.3% test sample and the cosmetic raw materials described in Table 7 were mixed at a ratio of 1: 1, and left at the pH and appearance immediately after that and at each temperature for one week, and the appearance was observed.
(表7)
○:変化なし、△:濁り発生、×:沈殿発生
(Table 7)
○: No change, △: Turbidity, ×: Precipitation
この表7の結果より、本発明に係るペラゴ藻抽出物含有組成物(実施例1)を化粧品原料と混合した溶液の安定性は、1週間各温度で放置後の外観に変化は見られず、化粧品原料として性状的安定性が確認された。 From the results in Table 7, the stability of the solution obtained by mixing the composition containing the extract of Pelago algae (Example 1) according to the present invention with a cosmetic raw material does not change in appearance after standing at each temperature for one week. The property stability was confirmed as a cosmetic raw material.
[実施例2]
この実施例2においては、以下のようにして製造した。
(アルコールによる抽出物の抽出方法)
収穫した藻体を脱塩処理後、凍結乾燥を行い、得られた乾燥藻体10gに50%エタノール100mLを加え、90℃以上で3時間還流抽出を行った。その後、遠心分離を行い、上清をガラスフィルターにてろ過をした後、エタノールを完全に除去して凍結乾燥して粉末を得て、これを実施例2とした。
[Example 2]
In Example 2, it was manufactured as follows.
(Extraction method of extract with alcohol)
The harvested algal bodies were desalted and then lyophilized. To 10 g of the obtained dried algal bodies, 100 mL of 50% ethanol was added, and reflux extraction was performed at 90 ° C. or higher for 3 hours. Thereafter, centrifugation was performed, and the supernatant was filtered through a glass filter. Then, ethanol was completely removed and freeze-dried to obtain a powder, which was designated as Example 2.
[試験例7]
この試験例7においては、前記実施例1および前記実施例2について、下記の方法でその抗菌活性を測定した。その結果を表8に示す。
(チャレンジテストによる抗菌試験方法)
各濃度に調製した被験試料1mL当たりに前培養した黄色ブドウ球菌(Staphylococcus aureus subsp.Aureus Rosenback 1884 IAM1011)を106個植菌し、25℃で保管した。生菌数の測定は、菌接種直後、1日後、3日後、7日後にSCDLP培地を使用し、30℃で48時間培養した。指標(比較例5)は通常化粧品の防腐剤として使用されているパラベンを使用した。
[Test Example 7]
In Test Example 7, the antibacterial activity of Example 1 and Example 2 was measured by the following method. The results are shown in Table 8.
(Antimicrobial test method by challenge test)
10 6 S. aureus ( Staphylococcus aureus subsp. Aureus Rosenback 1884 IAM1011) pre-cultured per 1 mL of the test sample prepared at each concentration was inoculated and stored at 25 ° C. The number of viable cells was measured immediately after inoculation, 1 day, 3 days, and 7 days after using SCDLP medium and culturing at 30 ° C. for 48 hours. As an index (Comparative Example 5), paraben which is usually used as a preservative for cosmetics was used.
(表8)
(単位:cfu/mL)
(Table 8)
(Unit: cfu / mL)
この表8の結果より、本発明に係る実施例1のペラゴ藻抽出物含有組成物について抗菌力を測定した結果は、黄色ブドウ菌に対する抗菌活性は認められなかったが、前記実施例2の50%エタノールにより抽出したペラゴ藻抽出物含有組成物の黄色ブドウ菌に対する抗菌活性は、通常化粧品の防腐剤として使用されているパラベンの2000倍の抗菌活性が認められた。 From the results of Table 8, the antibacterial activity of the Pelago algae extract-containing composition of Example 1 according to the present invention was measured. As a result, antibacterial activity against Staphylococcus aureus was not observed. The antibacterial activity of the composition containing Pelago algae extracted with% ethanol against Staphylococcus aureus was 2000 times that of parabens, which are usually used as preservatives in cosmetics.
アトピー性皮膚炎や化粧品のアレルギー疾患、更に近年の生活習慣によって敏感肌となる患者が増えている中で、化粧品に使用する原料の選択が重要となる。実施例2の50%エタノールにより抽出したペラゴ藻抽出物含有組成物は天然原料から抽出し、その使用量も少ない防腐剤として、期待のできる化粧品原料である。 With the increasing number of patients with sensitive skin due to atopic dermatitis, cosmetic allergic diseases, and recent lifestyles, the selection of raw materials used in cosmetics is important. The Pelago algae extract-containing composition extracted from 50% ethanol in Example 2 is a cosmetic raw material that can be expected as a preservative that is extracted from natural raw materials and uses a small amount.
これら熱水によって抽出したペラゴ藻抽出物含有組成物(実施例1)およびアルコールによって抽出したペラゴ藻抽出物含有組成物(実施例2)は、食品または化粧料等に配合させることによって、その作用を有する商品として応用することができる。以下、食品または化粧料にペラゴ藻抽出物含有組成物を配合させた場合について説明する。 The action of the Pelago algae extract-containing composition extracted with hot water (Example 1) and the Pelago algae extract-containing composition extracted with alcohol (Example 2) are combined with food or cosmetics to achieve the action. It can be applied as a product having Hereinafter, the case where the composition containing Pelago algae extract is mixed with food or cosmetics will be described.
[実施例3]
この実施例3においては、ペラゴ藻抽出物含有組成物を配合した食品の一例として、前記実施例1を0.1%配合したクッキーを表9に示した組成で製造した。なお、食品としては、前記クッキーに限るものではなく、例えば、機能性食品、飴、トローチ、ガム、ヨーグルト、アイスクリーム、プディング、ゼリー、水ようかん、ふりかけ、コーヒー飲料、ジュース、炭酸飲料、清涼飲料水、牛乳、乳清飲料および乳酸菌飲料等を含むいずれの食品であっても良く、また、食品添加物または飼・餌料等に配合させることもできる。
[Example 3]
In Example 3, a cookie containing 0.1% of Example 1 was produced with the composition shown in Table 9 as an example of a food containing the Pelago algae extract-containing composition. The food is not limited to the above-mentioned cookies. For example, functional foods, strawberries, troches, gums, yogurts, ice creams, puddings, jellies, mizuyokan, sprinkles, coffee drinks, juices, carbonated drinks, soft drinks Any food containing water, milk, whey drink, lactic acid bacteria drink, etc. may be used, and it can also be added to food additives or feed / food.
(表9)
(Table 9)
[実施例4]
この実施例4においては、ペラゴ藻抽出物含有組成物を配合した化粧料の一例として、前記実施例1を0.3%配合したローションを表10に示した組成で常法により製造した。
[Example 4]
In Example 4, a lotion containing 0.3% of Example 1 was prepared in a conventional manner with the composition shown in Table 10 as an example of a cosmetic containing the Pelago algae extract-containing composition.
(表10)
(Table 10)
[実施例5]
この実施例5においては、ペラゴ藻抽出物含有組成物を配合した化粧料の一例として、前記実施例2を0.1%配合したローションを表11に示した組成で常法により製造した。
[Example 5]
In Example 5, a lotion containing 0.1% of Example 2 was prepared in a conventional manner with the composition shown in Table 11 as an example of a cosmetic containing the Pelago algae extract-containing composition.
(表11)
(Table 11)
なお、化粧料としては、前記ローションに限るものではなく、例えば、化粧水、乳液及びクリーム等を含むいずれの化粧料であっても良く、また、シャンプー、ボディシャンプー、リンス、石鹸等を含む医薬部外品等に配合させることもできる。 The cosmetic is not limited to the lotion, and may be any cosmetic including, for example, lotion, milky lotion, cream and the like, and a pharmaceutical containing shampoo, body shampoo, rinse, soap, and the like. It can also be incorporated into quasi-drugs.
Claims (3)
該乾燥藻体に水を加えて90℃以上で3時間攪拌抽出を行った後、遠心分離による上清を濾過した熱水抽出液を1/5〜1/6まで濃縮し、これにエタノールを添加して一晩放置後の沈殿物として得られるか、または、
前記乾燥藻体に50%エタノールを加えて90℃以上で3時間還流抽出を行った後、遠心分離による上清を濾過し、エタノールを完全除去して得られた
ヒアルロニダーゼ阻害活性、抗酸化活性、保湿能及び抗菌活性を合わせ持つ抽出物を含有していること
を特徴とするペラゴ藻抽出物含有組成物。 Freeze-dry the algal bodies of sarcinolysis, which is a yellow plant gate Pelagophyceae sarcinolysis, after desalting,
After adding water to the dried alga body and stirring and extracting at 90 ° C. or more for 3 hours , the hot water extract obtained by filtering the supernatant by centrifugation is concentrated to 1/5 to 1/6, and ethanol is added to this. Obtained as a precipitate after being added and left overnight, or
It was obtained by adding 50% ethanol to the dried alga body and performing reflux extraction at 90 ° C. or higher for 3 hours , and then filtering the supernatant by centrifugation to completely remove ethanol.
A composition containing an extract of Pelago algae, comprising an extract having hyaluronidase inhibitory activity, antioxidant activity, moisturizing ability and antibacterial activity .
を特徴とする食品。 A food comprising 0.1% of the Pelago algae extract-containing composition according to claim 1.
を特徴とする化粧料。 A cosmetic comprising 0.1 to 0.3% of the Pelago algae extract-containing composition according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007298966A JP5538675B2 (en) | 2007-11-19 | 2007-11-19 | Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007298966A JP5538675B2 (en) | 2007-11-19 | 2007-11-19 | Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009120575A JP2009120575A (en) | 2009-06-04 |
| JP5538675B2 true JP5538675B2 (en) | 2014-07-02 |
Family
ID=40813122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007298966A Expired - Fee Related JP5538675B2 (en) | 2007-11-19 | 2007-11-19 | Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5538675B2 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005281397A (en) * | 2004-03-29 | 2005-10-13 | Kochi Univ Of Technology | Polysaccharides obtained from unicellular algae envelopes |
-
2007
- 2007-11-19 JP JP2007298966A patent/JP5538675B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009120575A (en) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4771379B2 (en) | Fermentation and culture method, plant fermented extract, plant fermented extract powder and blended plant fermented extract | |
| JP5737646B2 (en) | Antiallergic agent | |
| KR101862568B1 (en) | Composition for Prevention or Improving of Atopic Dermatitis Comprising Herbal Fermentation Product with microorganism | |
| JP2020090544A (en) | Cosmetics and food and drink composition | |
| JP4624742B2 (en) | Fermented material obtained from perilla leaves | |
| JP7458660B2 (en) | Profilaggrin mRNA expression promoter, serine palmitoyltransferase mRNA expression promoter, and hyaluronic acid synthase 3 mRNA expression promoter | |
| CN111358735A (en) | Lactobacillus rice fermentation product and preparation method thereof | |
| KR20160040498A (en) | Hyaluronidase Inhibitor Including Extrat of Styrax japonica and the Phamaceutical Composition Comprising the Same | |
| CN111529474A (en) | Multi-effect composition for moisturizing, whitening and antioxidant repair and preparation method and application thereof | |
| CN111184681A (en) | Acne-blackhead-removing essence and preparation method thereof | |
| KR101813618B1 (en) | Antioxidant Composition Using Fermentation Products of Opuntia ficus-indica and Broccoli | |
| KR20130079146A (en) | Compositoin for improving atopic dermatitis | |
| CN106491511A (en) | A kind of flesh can repair water light essence | |
| KR102503339B1 (en) | A cosmetic composition comprising a fermented product of donkey milk of complex probiotics, a functional cosmetic product including the cosmetic composition, a method for producing the fermented product and a method for producing the cosmetic composition | |
| JP5538675B2 (en) | Pelago algae extract-containing composition, food and cosmetics containing the Pelago algae extract-containing composition | |
| KR20180126912A (en) | A composition for water tissue containing lava seawater | |
| JPH06329545A (en) | Hyaluronidase inhibitor containing galenical extract as active ingredient | |
| JP5684989B2 (en) | Enzyme-treated and gonococcal fermentation-treated product | |
| JP2003055245A (en) | Skin cosmetic and food and beverage | |
| JP2000139451A (en) | Intestinal butyric acid bacteria growth promoter | |
| JP5058414B2 (en) | Skin cosmetics and food and drink | |
| CN103191036B (en) | Sweet tea extract-contained toothpaste | |
| KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
| JP4514181B2 (en) | Anti-periodontal agent | |
| KR20150146097A (en) | Hyaluronidase Inhibitor Including Extrat of Styrax japonica and the Phamaceutical Composition Comprising the Same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100915 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120316 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130208 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131105 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140203 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140212 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140408 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5538675 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140430 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |